Condition: Neovascular Age-Related Macular Degeneration · Sponsor: Hoffmann-La Roche
This study will evaluate the long-term safety and tolerability of the Port Delivery System with ranibizumab (PDS) (100 mg/mL) in participants with neovascular age-related macular degeneration (nAMD) who have either completed Phase II Study GX28228 (Ladder), Phase III Study GR40548 (Archway), Phase IIIb Study WR42221 (Velodrome), or completed Week 24 visit in Study WR42221 but were not eligible to be randomized in WR42221.
This description comes directly from the study's public registry record.
Reference Study ID Number: GR40549 https://forpatients.roche.com/ No attachments to email below. · 888-662-6728 (U.S. and Canada) · global-roche-genentech-trials@gene.com
Fastest response: use the inquiry form. https://www.gene.com/contact-us/submit-medical-inquiry
Always discuss trial participation with your own doctor first.
| Retinal Research Institute, LLC | Phoenix, Arizona, United States | Completed |
| Arizona Retina and Vitreous Consultants | Phoenix, Arizona, United States | Completed |
| Barnet Dulaney Perkins Eye Center | Phoenix, Arizona, United States | Active Not Recruiting |
| Associated Retina Consultants | Phoenix, Arizona, United States | Completed |
| Retinal Consultants of Arizona | Phoenix, Arizona, United States | Completed |
| California Retina Consultants | Bakersfield, California, United States | Completed |
| Retina-Vitreous Associates Medical Group | Beverly Hills, California, United States | Completed |
| The Retina Partners | Encino, California, United States | Active Not Recruiting |
| Jacobs Retina center at the Shiley eye Institute UCSD | La Jolla, California, United States | Completed |
| Jules Stein Eye Institute/ UCLA | Los Angeles, California, United States | Completed |
| N CA Retina Vitreous Assoc | Mountain View, California, United States | Completed |
| Retina Consultants, San Diego | Poway, California, United States | Completed |
+ 153 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT03683251